TEVA 7391 (Risedronate Sodium 30 mg)
Pill with imprint TEVA 7391 is White, Round and has been identified as Risedronate Sodium 30 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7391
Risedronate Sodium
- Imprint
- TEVA 7391
- Strength
- 30 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-3100
- Inactive Ingredients
-
silicon dioxide,
corn starch,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
sodium stearyl fumarate,
titanium dioxide,
polysorbate 80
Note: Inactive ingredients may vary.
More about risedronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (66)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.